Stock listing
IMMX Stock Price, News, Filings & Events — Immix Biopharma, Inc.
Selected listing: IMMX · NASDAQ · USD · US
This page tracks Immix Biopharma, Inc.'s IMMX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMMX:NASDAQ. IMMX:NASDAQ is the stock-level entry point for investors researching Immix Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immix Biopharma, Inc. is a public company traded under the ticker IMMX in the American market. The company has a market capitalization of approximately $606.5 million. Immix Biopharma focuses on developing innovative therapies in the biopharmaceutical sector.
- Ticker
- IMMX:NASDAQ
- Asset type
- Stock
- Market cap
- $784.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Immix Biopharma, Inc. IMMX:NASDAQ stock context
This page tracks Immix Biopharma, Inc.'s IMMX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMMX:NASDAQ. IMMX:NASDAQ is the stock-level entry point for investors researching Immix Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immix Biopharma, Inc. is a public company traded under the ticker IMMX in the American market. The company has a market capitalization of approximately $606.5 million. Immix Biopharma focuses on developing innovative therapies in the biopharmaceutical sector.
Latest news from Immix Biopharma, Inc.
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
September 30, 2026
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
September 29, 2026
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
August 4, 2026
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
May 22, 2026
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock
May 21, 2026
Research Immix Biopharma, Inc.
Immix Biopharma, Inc. investor report
Review AI stock analysis and investor report context for IMMX:NASDAQ.
Immix Biopharma, Inc. company profile
View the public company page for Immix Biopharma, Inc. on 6ix.
Immix Biopharma, Inc. news
Read company news and market updates connected to Immix Biopharma, Inc..
Immix Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Immix Biopharma, Inc..